CYP17A1 and benign prostatic hyperplasia: A non-significant relationship between CYP17 (rs743572) gene polymorphism and risk of BPH was observed under dominant model (OR = 0.96, 95% CI = 0.87–1.06) and recessive model (OR = 0.82, 95% CI = 0.60–1.13), respectively (Table 2, Supplementary Fig. S1A).